+

WO2002011675A3 - Element nutritif organique destine au traitement de la calvitie - Google Patents

Element nutritif organique destine au traitement de la calvitie Download PDF

Info

Publication number
WO2002011675A3
WO2002011675A3 PCT/US2001/025257 US0125257W WO0211675A3 WO 2002011675 A3 WO2002011675 A3 WO 2002011675A3 US 0125257 W US0125257 W US 0125257W WO 0211675 A3 WO0211675 A3 WO 0211675A3
Authority
WO
WIPO (PCT)
Prior art keywords
hair loss
composition
present
treatment
organic nutrient
Prior art date
Application number
PCT/US2001/025257
Other languages
English (en)
Other versions
WO2002011675A2 (fr
Inventor
M D Brian D Zelickson
Original Assignee
M D Brian D Zelickson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M D Brian D Zelickson filed Critical M D Brian D Zelickson
Priority to AU2001283322A priority Critical patent/AU2001283322A1/en
Publication of WO2002011675A2 publication Critical patent/WO2002011675A2/fr
Publication of WO2002011675A3 publication Critical patent/WO2002011675A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention concerne une composition généralement utile dans le traitement de la peau et des cheveux. Plus particulièrement, cette composition est utile dans le traitement de l'alopécie androgénétique, également connue sous le nom de calvitie commune ou de pelade. De manière générale, le composition de l'invention contient un ou plusieurs phytoestrogènes, un ou plusieurs extraits naturels d'herbes, et éventuellement un excipient pharmaceutiquement et/ou dermatologiquement acceptable. D'autres modes de réalisation de l'invention comprennent un ou plusieurs phytoestrogènes, un ou plusieurs extraits naturels d'herbes, une ou plusieurs substances choisies dans le groupe constitué par des vitamines, et notamment des complexes de vitamine B, des minéraux et de la levure de bière, et éventuellement un excipient pharmaceutiquement et/ou dermatologiquement acceptable.
PCT/US2001/025257 2000-08-10 2001-08-10 Element nutritif organique destine au traitement de la calvitie WO2002011675A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001283322A AU2001283322A1 (en) 2000-08-10 2001-08-10 Organic nutrient for hair loss treatment

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63709700A 2000-08-10 2000-08-10
US09/637,097 2000-08-10
US71117200A 2000-11-09 2000-11-09
US09/711,172 2000-11-09

Publications (2)

Publication Number Publication Date
WO2002011675A2 WO2002011675A2 (fr) 2002-02-14
WO2002011675A3 true WO2002011675A3 (fr) 2002-08-08

Family

ID=27092761

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/025257 WO2002011675A2 (fr) 2000-08-10 2001-08-10 Element nutritif organique destine au traitement de la calvitie

Country Status (2)

Country Link
AU (1) AU2001283322A1 (fr)
WO (1) WO2002011675A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10120315A1 (de) * 2001-04-26 2002-10-31 Beiersdorf Ag Verwendung von Klee-Extrakt in kosmetischen oder dermatologischen Zubereitungen zur Prophylaxe gegen und Behandlung von degenerativen Hauterscheinungen
US8668914B2 (en) 2002-07-24 2014-03-11 Brigham Young University Use of equol for treating skin diseases
EP1545206B1 (fr) 2002-07-24 2020-03-04 Children's Hospital Medical Center Compositions et produits contenant de l'equol enantiomere, et procedes de fabrication
CA2504682A1 (fr) 2002-10-29 2004-05-13 Colorado State University Research Foundation Utilisation d'equol dans le traitement de maladies d'origine androgenique
US8580846B2 (en) 2002-10-29 2013-11-12 Brigham Young University Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders
DE102004039983A1 (de) * 2004-08-12 2006-03-02 Keller, Ben Pharmazeutische oder kosmetische Zusammensetzung
WO2006042370A1 (fr) * 2004-10-20 2006-04-27 Novogen Research Pty Ltd Méthodes et préparations pour cheveux et ongles
KR101500020B1 (ko) * 2007-03-12 2015-03-06 디에스엠 아이피 어셋츠 비.브이. 미용 조성물
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
FR2996128B1 (fr) * 2012-09-28 2015-01-02 Inneov Lab Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles.
WO2014120793A1 (fr) * 2013-01-30 2014-08-07 The Beauty Cartel, Llc. Compositions de traitement de la perte des cheveux et procédés pour les fabriquer et les utiliser
DE102017008429A1 (de) 2017-09-07 2019-03-07 Dr. Theiss Naturwaren Gmbh Mittel zur Haarbehandlung

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007381A1 (fr) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions et traitements permettant de reduire les effets secondaires lies a l'administration des precurseurs de la testosterone androgenique
US5972345A (en) * 1999-05-03 1999-10-26 Chizick; Stephen Natural preparation for treatment of male pattern hair loss
US6017893A (en) * 1997-08-29 2000-01-25 Natures Sunshine Products, Inc. Use of isoflavones to prevent hair loss and preserve the integrity of existing hair

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007381A1 (fr) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions et traitements permettant de reduire les effets secondaires lies a l'administration des precurseurs de la testosterone androgenique
US6017893A (en) * 1997-08-29 2000-01-25 Natures Sunshine Products, Inc. Use of isoflavones to prevent hair loss and preserve the integrity of existing hair
US5972345A (en) * 1999-05-03 1999-10-26 Chizick; Stephen Natural preparation for treatment of male pattern hair loss

Also Published As

Publication number Publication date
WO2002011675A2 (fr) 2002-02-14
AU2001283322A1 (en) 2002-02-18

Similar Documents

Publication Publication Date Title
CA2250528A1 (fr) Preparation pour le traitement des cheveux et methode de fabrication de la preparation
WO2001074314A3 (fr) Compositions cosmetiques et pharmaceutiques et procedes d'utilisation de derives 2-decarboxy-2-phosphinico
WO2000057900A3 (fr) Facteur
WO2001052921A3 (fr) Systeme de soupape
MY114698A (en) A process for the isolation of galanthamine
CA2292965A1 (fr) Compositions a base de derives de pyrrolidine pour la pousse des cheveux et leurs utilisations
WO2001066564A3 (fr) Inhibiteurs de gamma-sécrétase
WO2002011675A3 (fr) Element nutritif organique destine au traitement de la calvitie
HUP0303656A3 (en) Modulators of bruton's tyrosine kinase, their identification and use
WO2003028691A3 (fr) Compositions stables contenant des derives d'ethanolamine et des glucosides
CA2392620A1 (fr) Melatonine servant a traiter l'alopecie androgenetique et diffuse
AU2002247876A1 (en) Herbal composition for treatment of neuronal injuries and neuronal degeneration, methods to prepare the same and uses thereof
WO2003015724A8 (fr) Substances capables de potentialiser la productivite de la laminine 5 dans des cellules epidermiques et utilisation desdites substances
AU2003216884A1 (en) Plant extracts and the use thereof
WO2004080380A3 (fr) Utilisation de polyphenols catechniques pour la preparation de compositions destinees a favoriser la pigmentation naturelle de la peau
PL346463A1 (en) Method of obtaining derivatives of resorcinol, method of obtaining novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, method of obtaining novel derivatives of 1,3-cyclohezandione, method of obtaining novel derivatives of 2-cyclohexanone, novel derivatives of 2-oxazabicyclo[2.2.2.]-octan-5-one, novel derivatives of 1,3-cyclohexanodione, and novel derivatives of 2-cyclohexenonea
WO2003039453A3 (fr) Compositions de peroxyde de dibenzoyle pour le traitement de troubles dermatologiques, et procedes d'utilisation correspondants
PL348781A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
WO2002008222A3 (fr) Derives de heteroaryle-beta-alanine en tant qu'inhibiteurs d'alpha-4-integrine
AU2001242130A1 (en) Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
WO2001039738A3 (fr) Utilisation de flavones et/ou d'isoflavones tirees d'extraits de plantes
WO2000026399A3 (fr) Procede de production de derives de quercetine et d'isoquercetine
WO2002056859A3 (fr) Composition contenant un extrait d'hedichium et utilisation de cette composition
AU4470497A (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical comp ositions, and method of cosmetic treatment using a ginkgo biloba extract
CA2505500A1 (fr) Methodes de stimulation de la croissance des cheveux au moyen de benzopyranes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载